Rational Drug Design of Substituted Analogues Angiotensin II Receptor

CHF 62.35
Auf Lager
SKU
KRCODP01AP9
Stock 1 Verfügbar
Geliefert zwischen Mo., 17.11.2025 und Di., 18.11.2025

Details

Hypertension has become one of the most important preventable causes for premature morbidity and mortality worldwide. To identify novel and potent antihypertensive ligands, initially 2D-QSAR, Group based QSAR, kNN based 3D-QSAR and pharmacophore were generated using namely, a series of triazolinone, quinazolinone, and benzimidazole derivatives of as Angiotensin II AT1 Receptor. In conclusion, the models developed to predict the structural features of substituted analogues angiotensin II receptor antagonists, reveals useful information about the structural features requirement for the molecule.

Autorentext

Dr.Mukesh C.Sharma research area in chemistry;exploring rational drug design aided by molecular modelling techniques and small molecule synthetic organic chemistry. His work includes modern analytical techniques such as UV-Spectrophotometric and high performance liquid chromatography.He has published research papers in reputed International Journal

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Mukesh C. Sharma , Smita Sharma
    • Titel Rational Drug Design of Substituted Analogues Angiotensin II Receptor
    • Veröffentlichung 23.05.2014
    • ISBN 3659542962
    • Format Kartonierter Einband
    • EAN 9783659542961
    • Jahr 2014
    • Größe H220mm x B150mm x T6mm
    • Untertitel Statistical approach QSAR for group-specific biological Activity Predictions;Different Series of Substituted Analogues
    • Gewicht 167g
    • Genre Medizin
    • Anzahl Seiten 100
    • Herausgeber LAP LAMBERT Academic Publishing
    • GTIN 09783659542961

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470